
Decriminalization supporters question B.C. drug study that links policy to overdoses
British Columbia’s former chief coroner is cautioning against a “jump to conclusions” after a new study found safer supply and drug decriminalization policies were associated with significant increases in opioid overdose hospitalizations in the province.
Lisa Lapointe, who retired from the post last year, said in an interview Wednesday that the study published in JAMA Health Forum last Friday did not provide the full picture on the effectiveness of the province’s drug policies, since it used data up to the end of 2023 and did not capture the “significant” decrease in toxic drug deaths in B.C. reported in 2024.
Toxic drug deaths last year fell 13 per cent from the year before, with the annual death toll lower than any year since 2020. Decriminalization of opioid possession was introduced in B.C. in January 2023 then heavily curtailed in May 2024. The ongoing safer supply program providing pharmaceutical-grade opioids to people at risk of overdosing was introduced in 2020.
“It would be interesting to see that study redone with the 2024 data,” said Lapointe, whose tenure as chief coroner put her on the forefront of B.C.’s fight against the opioid crisis that has claimed more than 16,000 lives since being declared a health emergency in 2016.